⚡ For Research Use Only — Not for Human Consumption
General8 min read

PEGylation: How PEG Chains Are Attached to Peptides and Proteins

PEGylation explained: what PEG and mPEG are, how amine, aldehyde, maleimide and click chemistries attach PEG to peptides, and how conjugates are analyzed.

Dynamite Research Team · October 31, 2026

Short answer: PEGylation is the covalent attachment of poly(ethylene glycol) (PEG) chains to a molecule such as a peptide or protein [1]. The PEG is first given a reactive functional group, which then couples to a matching group on the peptide, most often a free amine (the N-terminus or lysine side chains) or a free cysteine thiol [1][4]. PEG is flexible and hydrophilic [4], and attaching it can substantially change a protein's solubility, electrophoretic mobility and chromatographic behavior [2].

This article is educational chemistry for laboratory readers. It does not describe effects in people or animals and is not guidance for human or animal use.

What PEG is

PEG is a linear polymer built from repeating oxyethylene units, –(CH2–CH2–O)n– [5]. Its simplest form is a hydroxyl-terminated polyether, HO–(CH2CH2O)n–CH2CH2–OH [5]. For modifying peptides and proteins, the usual starting material is monomethoxy PEG (mPEG), in which one end is capped as a methyl ether, CH3O–(CH2CH2O)n–CH2CH2–OH [5].

A few properties matter for conjugation work:

  • Hydration: in water, each –CH2–CH2–O– unit binds two to three water molecules [5].
  • Size range: linear and branched PEGs used with proteins and peptides typically range from 3 to 60 kDa [5].
  • Repeat mass: one PEG unit weighs 44 Da, less than glycine, the smallest amino acid residue, at 57 Da [8].
  • Shape in solution: PEG behaves as a random coil, and singly branched PEGs had Stokes radii identical to those of their linear counterparts in one hydrodynamic study [9].

A short history

PEGylation of proteins began in the laboratory of Frank Davis in the late 1970s [4]. In 1977, Abuchowski and colleagues attached methoxy-PEGs of 1,900 and 5,000 Da to bovine serum albumin, using cyanuric chloride as the coupling agent [2]. The modified albumin showed substantial changes in solubility, electrophoretic mobility in acrylamide gel, ion-exchange chromatography and sedimentation compared with the unmodified protein [2].

A companion 1977 study coupled the same PEG sizes to bovine liver catalase [3]. In the test tube, PEG-1900-catalase kept 93% of its enzymatic activity and PEG-5000-catalase kept 95% [3]. PEG-5000-catalase also resisted digestion by trypsin, chymotrypsin and a protease from Streptomyces griseus [3].

These early methods modified amino groups non-selectively [4]. A 2016 review counted PEGylation in 12 approved drugs, using both linear and branched PEG reagents up to 40 kDa [14].

Why chemists PEGylate peptides

A chemistry review lists several reasons for attaching PEG [1]:

  • Shielding: the attached chain can hide the molecule from recognition and degradation by proteolytic enzymes [1].
  • Apparent size: conjugation increases the apparent size of the polypeptide [1].
  • Solubility and handling: in a 2024 synthesis study, adding a PEG chain to hydrophobic peptide sequences 9 to 38 residues long significantly improved solubility and made single-step purification of long hydrophobic peptides possible [8].
  • Solution stability: researchers have used N-terminal PEGylation of oxytocin, a cyclic nine-residue peptide, specifically to try to stabilize it in aqueous formulations during storage at elevated temperature [12].
The PEG chain does not stay inert in the background, though. Almost all PEGylated therapeutic proteins show some decrease in specific activity compared with the unmodified form [4]. Where the chain sits matters too, as the next sections show.

How PEG is attached: the main chemistries

The general plan is simple: a functional group on the protein reacts with a complementary group on the PEG to form the conjugate [4]. The choice of PEG reagent decides which residue gets modified.

Amine-reactive PEG (lysine and the N-terminus)

The most common targets are amino groups: the N-terminal amine and the lysine side chains on the molecule's surface [5]. Amines are the most frequently modified group in this chemistry and have high nucleophilic reactivity [5]. Succinimidyl (NHS) ester PEGs were the coupling reagent for 7 of the 10 FDA-approved PEGylated proteins listed in one review [4]. In one study with PEG–N-hydroxysuccinimide (PEG-NHS) reagents, pH played a crucial role in reaching optimal conditions [5].

The drawback is heterogeneity. A protein usually has many free amines, so random modification can lower activity and give a mixed final product [5]. A cited example from the protein literature: PEGylating interferon-α2a produced eight different PEGylated forms through eight different lysine residues, and their activities spanned a three-fold range [4]. (Our N-terminus vs C-terminus guide explains where the free alpha-amine sits on a chain.)

N-terminal selective PEGylation (aldehyde chemistry)

Reductive alkylation with a PEG-aldehyde at lower pH gives essentially homogeneous products with a single PEG chain on the amine terminus [6]. The selectivity comes from pKa:

  • The N-terminal alpha-amino group has a pKa of about 7.8 [4].
  • The lysine epsilon-amino group has a pKa of about 10.1 [4].
  • Under acidic conditions the lysine amines are predominantly protonated and cannot react with the aldehyde, so the N-terminal amine is labeled preferentially [4].
The reaction forms a secondary amine link between the PEG and the protein [4]. (For more on how pH sets the charge state of amino groups, see our isoelectric point guide.)

Thiol-reactive PEG (cysteine)

The most common thiol method reacts a single free cysteine with a PEG-maleimide [4]. It can be site-specific because cysteine makes up less than 1% of the amino acids in proteins, and many cysteines are tied up in disulfide bonds that do not react with thiol-specific reagents [4]. The method needs exactly one free cysteine; with more than one, a heterogeneous mixture can form [4].

A related approach targets a native disulfide: the bond is reduced under mild conditions and both freed cysteines react with a bridging PEG reagent [4]. (See our disulfide bond guide.)

Other routes

  • Click chemistry: an alkyne built into a peptide during solid-phase synthesis can be joined to an azide-PEG by the Huisgen 1,3-dipolar cycloaddition, the "click" reaction [4].
  • Enzymatic labeling: enzymes including sortase and transglutaminase have been used to install PEG or a handle for it [4].
  • During synthesis: a monodisperse Fmoc-PEG building block can be coupled at the N-terminus as part of standard Fmoc/tBu solid-phase peptide synthesis [8]. (Our peptide synthesis guide covers SPPS.)
  • Reversible linkages: reviews also cover reversible PEGylation [1][7]. One oxytocin study tested a reversible Schiff-base linkage, designed to release the native peptide, alongside irreversible NHS-ester and aldehyde reductive-amination chemistries [12].

Linear, branched and "generations" of PEG reagents

PEG reagents are often grouped by generation [5]:

  • First generation: activated reagents such as PEG succinimide carbonate, PEG benzotriazole carbonate, PEG dichlorotriazine, PEG tresylate and PEG p-nitrophenyl carbonate [5]. This group is noted for instability and poor homogeneity of the products [5].
  • Second generation: more specific functional groups such as aldehydes for the N-terminus and maleimides for thiols [5].
  • Third generation: branched architectures such as Y-type, tree-type and comb-type PEGs [5].
Five main PEG material types are in use: linear, Y-shaped, multiarm, fork-shaped and branched [5]. Compared with linear PEG, branched PEG modifiers have reduced access to hidden sites and greater stability against proteolysis [5].

How PEGylated peptides are characterized

PEGylation complicates analysis because the PEG itself is heterogeneous, and both the number of PEG chains and the attachment sites can vary [10]. Problems flagged in the literature include working out how many PEG chains are bound and where on the polypeptide they sit [7].

  • Mass spectrometry: large, polydisperse PEGylated molecules give congested electrospray spectra [11]. One LC/MS approach adds an amine after the column so the PEG carries far fewer charges, giving mass accuracies better than 0.01% [10]. Tandem LC/MS can then locate the PEGylation sites [15]. (See our mass spectrometry peptide testing guide.)
  • Hidden impurities: low-abundance free PEG in a PEGylated peptide preparation is not directly detectable by mass spectrometry alone; combining charge reduction with ion mobility made it measurable in one study [11]. The same work saw a 16 Da mass shift from an oxidized form of a PEGylated protein [11].
  • Size methods need care: for PEGylated lysozyme, the sedimentation coefficient stayed the same as more PEG chains were added, because extra mass was offset by extra frictional drag [9]. The authors cautioned against using sedimentation velocity alone to judge size heterogeneity of PEG-protein mixtures [9].
  • Oligomer purity: one PEG unit (44 Da) is lighter than glycine (57 Da), so PEG chain-length impurities make peptide purification harder [8]. One synthesis group therefore started from monodisperse, high-purity PEG and checked for n−2, n−1 and n+1 oligomer impurities by LC–MS [8]. (For how impurities affect a purity figure, see our peptide purity and HPLC peptide testing guides.)

PEG and self-assembly

PEG–peptide conjugates are also studied as materials. A review describes a wide variety of self-assembly behavior for PEG-peptides, including conjugates built on beta-sheet and alpha-helical (coiled-coil) sequences, in solution and in the solid state [13]. (See our beta sheet and alpha helix guides.)

FAQ

What does PEGylation mean?
It is the covalent attachment of poly(ethylene glycol) chains to a molecule such as a peptide or protein [1].

Which amino acids are PEGylated?
Most often the N-terminal amine and lysine side-chain amines, or a free cysteine thiol [4][5]. Click and enzymatic methods can target engineered handles [4].

How is N-terminal-only PEGylation achieved?
By reacting a PEG-aldehyde at lower pH, where lysine amines (pKa about 10.1) stay protonated but the N-terminal amine (pKa about 7.8) can still react [4][6].

What is mPEG?
Monomethoxy PEG, a PEG with one end capped as a methyl ether, the usual starting material for modifying peptides and proteins [5].

Why are PEGylated peptides hard to analyze?
PEG reagents are heterogeneous, and the number and position of attached chains can vary, which complicates mass spectrometry and size-based methods [9][10][11].

Bottom line

PEGylation links poly(ethylene glycol) to a peptide or protein through an activated PEG reagent [1]. Amine-reactive esters are common but give mixtures [4][5], aldehydes at lower pH favor the N-terminus [4][6], and maleimides target a single free cysteine [4]. The PEG chain changes size, solubility and handling [1][8][9], and its own heterogeneity makes careful LC/MS and orthogonal methods necessary for characterization [10][11].


All products are for research use only — not for human or animal consumption.

References

Peer-reviewed studies referenced in this article. Links open the published source on PubMed / PubMed Central.

  1. 1. Chemistry for peptide and protein PEGylation — Adv Drug Deliv Rev, 2002.
  2. 2. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol — J Biol Chem, 1977.
  3. 3. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase — J Biol Chem, 1977.
  4. 4. Site-specific PEGylation of therapeutic proteins — Int J Mol Sci, 2015.
  5. 5. Research progress on the PEGylation of therapeutic proteins and peptides (TPPs) — Front Pharmacol, 2024.
  6. 6. Mono-N-terminal poly(ethylene glycol)-protein conjugates — Adv Drug Deliv Rev, 2002.
  7. 7. Peptide and protein PEGylation: a review of problems and solutions — Biomaterials, 2001.
  8. 8. Impact of N-terminal PEGylation on synthesis and purification of peptide-based cancer epitopes for pancreatic ductal adenocarcinoma (PDAC) — ACS Omega, 2024.
  9. 9. Effect of PEGylation on protein hydrodynamics — Mol Pharm, 2012.
  10. 10. Characterization of poly(ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines — Anal Chem, 2009.
  11. 11. Gas-phase proton-transfer chemistry coupled with TOF mass spectrometry and ion mobility-MS for the facile analysis of poly(ethylene glycols) and PEGylated polypeptide conjugates — Anal Chem, 2008.
  12. 12. Stability enhancing N-terminal PEGylation of oxytocin exploiting different polymer architectures and conjugation approaches — Biomacromolecules, 2016.
  13. 13. PEG-peptide conjugates — Biomacromolecules, 2014.
  14. 14. PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs — J Pharm Sci, 2016.
  15. 15. Characterization of PEGylated biopharmaceutical products by LC/MS and LC/MS/MS — Methods Mol Biol, 2012.

⚠ Research Use Only

All information on this page is for informational and research purposes only. This content does not constitute medical advice. All products sold by Dynamite Research Peptides are strictly for in-vitro laboratory research and are not approved, intended, or suitable for human or animal consumption. The products sold here are not FDA-approved drugs.

© 2026 Dynamite Research Peptides. All content for research purposes only.